Live Cell Imaging Market – Overview
The Global Live Cell Imaging Market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the global live cell imaging market is expected to grow at a CAGR ~9.0 % during the forecast period of 2018–2023.
Live cell imaging is the technique to study live cells with the help of images obtained from imaging systems such as high content screening systems and microscopes. The increasing prevalence of chronic diseases and growing government funding in cell-based research are propelling the growth of this market. For instance, funding institutes such as Health Connexions, National Institute of Health, and W.M. Keck Foundation have granted funds to institutes such as Harvard School of Medicine, Perdue University, and Weldon School of Biomedical Engineering for the development of imaging technologies to be applied in the field of health, food, and environment. Furthermore, adoption of high content screening techniques in drug discovery and cell biology boosts the growth of the global live cell imaging market. However, the lack of availability of skilled professional and the high cost of high-content screening systems may hinder the growth of the market during the forecast period.
Industry News:
April 2016, BioTek Instruments launched Lionheart FX, an automated live cell imager with augmented microscopy. Moreover, the company announced the collaboration with MilliporeSigma for long-term dynamic time-lapse analyses and live cell experiments. This collaboration involved the development of an integrated solution comprising MilliporeSigma’s CellASIC ONIX2 Microfluidic system and BioTek’s Lionheart FX Automated Live Cell Imager.
Avail Premium Sample copy at https://www.marketresearchfuture.com/sample_request/6075
Live Cell Imaging Market – Top Players
Carl Zeiss AG (Germany), Leica Microsystems (Germany), Olympus Corporation (Japan), Sigma-Aldrich Corporation (U.S.), Nikon Corporation (Japan), Molecular Devices, LCC (U.S.), PerkinElmer, Inc. (U.S.), GE Healthcare (U.K.), Becton, Dickinson and Company (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Danaher Corporation (U.S.), and BioTek Instruments (U.S.) are some prominent players in this market.
Intended Audience
• Pharmaceutical Companies
• Biotechnological Companies
• Research and Development (R&D) Companies
• Government Research Institutes
• Academic Institutes and Universities
Global Live Cell Imaging Market – Regional Analysis;
The American region holds the major share of the global live cell imaging market, owing to the existing well-established healthcare system, increasing prevalence of cancer cases, and technological advancements. According to the report published by the American Cancer Society, 2017, around 190,500 of the estimated 600,920 cancer deaths in the United States are likely to be caused owing to cigarette smoking. Moreover, factors such as high capitalization in imaging systems as well as intensive research and development to improve the imaging quality and data functionality fuel the market growth in this region.
Europe holds the second position in the global live cell imaging market. It is expected that government support towards research & development expenditure and rising prevalence chronic diseases are likely to drive the European live cell imaging market. In addition, the presence of some key players such as Carl Zeiss AG, Leica Microsystems, and GE Healthcare in this region also facilitates the growth of this market. For instance, in November 2016, Carl Zeiss AG launched ZEISS celldiscover 7 automated microscope for live cell imaging. With this launch, the company expanded its product portfolio in live cell imaging.
The Asia Pacific live cell imaging market consists of countries, namely, China, Japan, the Republic of Korea, India, Australia, and the Rest of Asia Pacific. Japan is the largest market for live cell imaging due to an increase in the prevalence of cancer and demand for live cell imaging techniques. In China, factors responsible for the market growth are rising geriatric population with chronic diseases and availability of low-cost diagnostic and treatment options.
The Middle East & Africa holds the lowest share of the global market due to low development, lack of technical knowledge, and poor medical facilities.
Avail Stunning Discount at https://www.marketresearchfuture.com/check-discount/6075
Global Live Cell Imaging Market – Segmentation:
The global live cell imaging market is segmented on the basis of the product, technology, application, and end-user.
On the basis of product, the market is classified as equipment, consumables, and software. The equipment is further segmented as microscopes, standalone systems, cell analyzer, and image-capturing devices. The microscopes are further sub-segmented as conventional microscopes, confocal microscopes, and advanced fluorescence microscopes. The consumables are sub-segmented as assay kits, reagents, media, and others.
The global live cell imaging market on the basis of technology is segmented as fluorescence resonance energy transfer, fluorescence recovery after photobleaching, high-content analysis, ratiometric imaging, fluorescence in situ hybridization, total internal reflection fluorescence microscopy, multiphoton excitation microscopy and other technologies.
On the basis of application, the market is segmented into cell biology, stem cells, developmental biology, and drug discovery.
On the basis of end-user, the market is segmented as pharmaceutical companies, biotechnology companies, hospitals, diagnostic laboratories, and others.
Geographically, the global live cell imaging market has been segmented into America, Europe, Asia Pacific, and the Middle East and Africa. The American live cell imaging market is further segmented into North America and South America. North America is further classified as the U.S. and Canada. The Europe live cell imaging market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, U.K., Italy, Spain, and Rest of Western Europe. The Asia Pacific live cell imaging market is segmented into Japan, China, India, the Republic of Korea, Australia, and the Rest of Asia Pacific. The Middle East & Africa live cell imaging market is segmented into the Middle East and Africa.
Major TOC of Live Cell Imaging Market Research Report- Global Forecast till 2023
1 Introduction
2 Research Methodology
3 Market Dynamics
4 Market Factor Analysis
5 Global Live Cell Imaging Market, By Product
7 Global Live Cell Imaging Market, By Technology
8 Global Live Cell Imaging Market, By Application
9 Global Live Cell Imaging Market, By Region
10 Competitive Landscape
11 Company Profile
12 MRFR Conclusion
Have Any Query, Ask to Expert at https://www.marketresearchfuture.com/enquiry/6075
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Media Contact
Company Name: Market Research Future
Contact Person: Abhishek Sawant
Email: Send Email
Phone: +1 646 845 9312
Address:Market Research Future Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.marketresearchfuture.com